nuclivision

Foundation date

08/06/2022

Sector

#Medical Technology

Subsector

Nuclivision is a medical software company that wants to make nuclear imaging safer and more accessible. For our first product, we are developing an AI-solution that allows hospitals and research centers to perform PET-scans with less radiotracer and/or a shorter scan time. Nuclivision's technology results in significantly less radioactive exposure for the patient, while also reducing the costs for a nuclear department.

Upcoming events

Latest news

  • V-Bio Ventures leads €20 million Series A financing of Precision oncology company Flindr Therapeutics to advance first-in-class small molecule inhibitors

    Wednesday April 24th 2024

  • Labconsort and NEKTARI join forces for a more sustainable and social industry

    Saturday April 20th 2024

  • BIO INX Complements Advisory Board with Distinguished Industry Leaders

    Thursday April 18th 2024